Under the guidance of Prof Joanna Loizou, we are seeking a Higher Scientific Officer to carry out lab-based cell biology research focused on potential therapeutic targets in breast cancer. The successful candidate will also contribute to assay development and biomarker discovery for targets that move to a drug discovery phase within the ICR’s Centre for Cancer Drug Discovery.
About you
The successful candidate must have:
- An MSc (or equivalent) in cell biology or aligned subject
- Skills in cell biology techniques used for target validation
- Expertise in a range of biology readouts used for screening and biomarker detection
Department/Directorate Information
The Target Validation and Genome Stability Group, led by Professor Joanna Loizou, focuses on identifying vulnerabilities in the DNA damage response to generate pre-clinical information that can lead to the identification of novel targets for drug discovery programmes.
The teams sit within the Breast Cancer Now Toby Robins Research Centre, within the Division of Breast Cancer Research at The Institute of Cancer Research which is the first centre in the UK entirely devoted to breast cancer research. Our goal is to advance research into the causes, diagnosis and treatment of breast cancer. It is located in state-of-the-art laboratory space, with excellent core facilities and is funded through a long-term renewable programme grant from Breast Cancer Now.
What we offer
- A dynamic and supportive research environment
- Access to state-of-the-art facilities and professional development opportunities
- Collaboration with leading researchers in the field
- Competitive salary and pension